Please Note:
This profile was automatically generated using 6 references found on the Internet. This information has been verified by Mindy Brooks. Learn more...
This profile was automatically generated using 6 references found on the Internet. This information has been verified by Mindy Brooks. Learn more...
Employment History
View...Board Membership and Affiliations
View...Certifications
View...Biography
Mindy Brooks, PhD is a Business Development Consultant to the Biotech industry. She was formerly Senior Director of Business Development at Medarex, Inc., a mid-sized US therapeutic antibody company. Dr. Brooks was a member of the Medarex BD team for over six years, and was responsible for outlicensing Medarex's UltiMab platform technology and for putting in place drug co-development...View all 6 references Web References
-
1. Highlights: The California Biotechnology Mission to BioSquare 2003 - Lyon and Paris, France
www.bawtc.com/tradenews_detail - [Cached]Published on: 5/9/2003 Last Visited: 4/12/2007
"Found it to be useful and recommend you continue it and see if it is possible to include more CA companies," -- Mindy Brooks, Director of Business Development, Medarex, Milpitas, CA. PARTICIPATING CALIFORNIA MISSION FIRMS -
2. Accounting Standards in the New Economy
www.usa-canada.les.org/press/a - [Cached]Published on: 5/6/2005 Last Visited: 3/18/2008
Medarex Director of Business Development Mindy Brooks and Brindisi outlined the license agreement for BioWa (Kyowa subsidiary) Potelligent technology to be applied to antibodies developed by Metarex. -
3. Successful Deal-making With Major Japanese Partners Highlights Closing Sessions at Licensing Executives Society (USA and Canada) Inc. (LES) Meeting in Raleigh, North Carolina
www.prnewswire.com/cgi-bin/sto - [Cached]Published on: 5/6/2005 Last Visited: 5/6/2005
Medarex Director of Business Development Mindy Brooks and Brindisi outlined the license agreement for BioWa (Kyowa subsidiary) Potelligent technology to be applied to antibodies developed by Metarex.
